SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Not quite a myriad of gene patents
7 references·10 citing·49 second hop
Not quite a myriad of gene patents (2013)Not quite a myriad of gene patentsWas there too little entry during the Dot Com Era?☆ (2007)Was there too little entry du…The licensing of DNA patents by US academic institutions: an empirical survey (2006)The licensing of DNA patents …Intellectual Property Landscape of the Human Genome (2005)Intellectual Property Landsca…Owning the Genome: A Moral Analysis of DNA Patenting (2004)Owning the Genome: A Moral An…The public–private structure of intellectual property ownership in agricultural biotechnology (2003)The public–private structure …Patenting human genetic material: refocusing the debate (2000)Patenting human genetic mater…Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Can Patents Deter Innovation?…Models of Technology Transfer for Genome-Editing Technologies (2020)Models of Technology Transfer…International Divergence in Gene Patenting (2019)International Divergence in G…Patenting activity in the food safety sector (2018)Patenting activity in the foo…Mapping the Patent Landscape in the Field of Personalized Medicine (2017)Mapping the Patent Landscape …After Myriad, what makes a gene patent claim 'markedly different' from nature? (2017)After Myriad, what makes a ge…Myriad's impact on gene patents (2016)Myriad's impact on gene paten…Are the gene-patent storm clouds dissipating? A global snapshot (2015)Are the gene-patent storm clo…The European BRCA patent oppositions and appeals: coloring inside the lines (2013)The European BRCA patent oppo…Pervasive sequence patents cover the entire human genome (2013)Pervasive sequence patents co…AMP v. Myriad : A Surgical Strike on Blockbuster Business Models (2013)AMP v. Myriad : A Surgical St…Withholding Research Results in Academic Life Science (1997)Reforming the Patent System (2000)Needed: models of biotechnology intellectual property (2002)Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research (2004)A novel approach to identify the major research themes and development trajectory: The case of patenting research (2015)Spheres of Justice (1983)The Right to Private Property (1990)The impact of human gene patents on genetic testing in the United Kingdom (2010)Understanding genetic information as a commons: From bioprospecting to personalized medicine (2013)Pharmaceutical patenting and the transformation of American medical ethics (2016)Appropriating the Returns from Industrial Research and Development (1987)Standing on the Shoulders of Giants: Cumulative Research and the Patent Law (1991)Exploring the Foundations of Cumulative Innovation: Implications for Organization Science (2007)Has the Bayh-Dole act compromised basic research? (2011)Trends in sensitivity analysis practice in the last decade (2016)The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools (2001)The NBER Patent Citations Data File: Lessons, Insights and Methodological Tools (2001)Private and Common Property Rights (2007)The Economics of Pesticides and Pest Control (2007)Private and Common Property Rights (2011)Patents in Genomics and Human Genetics (2010)Crowdfunding genomics and bioinformatics (2013)Gene patents at the Supreme Court: Association for Molecular Pathology v. Myriad Genetics (2014)Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After the Bayh-Dole Act (2004)Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After the Bayh-Dole Act (2004)Role and reality: technology transfer at Canadian universities (2010)Bridging knowledge to commercialization: the good, the bad, and the challenging (2012)CRISPR, surrogate licensing, and scientific discovery (2017)Judgment under Uncertainty: Heuristics and Biases (1975)Governing the Commons (1990)Governing the Commons: The Evolution of Institutions for Collective Action (1992)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)The Knowledge Economy (2004)Profiting from innovation in the digital economy: Enabling technologies, standards, and licensing models in the wireless world (2018)The fate and future of patents on human genes and genetic diagnostic methods (2012)Patent landscaping for life sciences innovation: toward consistent and transparent practices (2013)The History of Patenting Genetic Material (2015)Continental drift? Do European clinical genetic testing laboratories have a patent problem? (2019)European patent protection for medical uses of known products and drug repurposing (2022)American universities and technical advance in industry (1994)Technology policy for a world of skew-distributed outcomes (2000)Governance Choices of Genome Editing Patents (2021)The Emergence of Genome Editing—Innovation Network Dynamics of Academic Publications, Patents, and Business Activities (2022)The Theory of Industrial Organization (1988)Econometric Analysis of Cross Section and Panel Data (2001)The Core Competence of the Corporation (2006)Getting Big Too Fast: Strategic Dynamics with Increasing Returns and Bounded Rationality (2007)Thought and Behavior Contagion in Capital Markets (2009)The study of emerging industries: Recognizing and responding to some central problems (2010)
this work references cited by second hop

References

  • 1998Can Patents Deter Innovation? The Anticommons in Biomedical Research2,575 cited
  • 2005Intellectual Property Landscape of the Human Genome222 cited
  • 2003The public–private structure of intellectual property ownership in agricultural biotechnology171 cited
  • 2007Was there too little entry during the Dot Com Era?☆134 cited
  • 2004Owning the Genome: A Moral Analysis of DNA Patenting86 cited
  • 2006The licensing of DNA patents by US academic institutions: an empirical survey73 cited
  • 2000Patenting human genetic material: refocusing the debate43 cited

Cited by

  • 2013Pervasive sequence patents cover the entire human genome37 cited
  • 2017After Myriad, what makes a gene patent claim 'markedly different' from nature?21 cited
  • 2020Models of Technology Transfer for Genome-Editing Technologies19 cited
  • 2016Myriad's impact on gene patents19 cited
  • 2017Mapping the Patent Landscape in the Field of Personalized Medicine16 cited
  • 2019International Divergence in Gene Patenting16 cited
  • 2013The European BRCA patent oppositions and appeals: coloring inside the lines15 cited
  • 2015Are the gene-patent storm clouds dissipating? A global snapshot

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

11 cited
  • 2013AMP v. Myriad : A Surgical Strike on Blockbuster Business Models11 cited
  • 2018Patenting activity in the food safety sector10 cited